Dasatinib 100 Mg Tablet 100 mg, 20 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 100 mg, 20 mg

Reference Brands: Phyrago (USA)

Category: Orphan Drugs

This medication is used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). It works by slowing or stopping the growth of cancer cells.

Product Description:

Dasatinib, marketed under the brand name Sprycel among others, is a targeted therapy used to treat specific types of leukemia. It is primarily indicated for patients with chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) who are Philadelphia chromosome-positive (Ph+). By inhibiting abnormal tyrosine kinase activity, dasatinib helps to control the growth and proliferation of cancerous cells, offering an effective treatment option for patients with these blood cancers.

This therapy works as a tyrosine kinase inhibitor, targeting BCR-ABL and other kinases involved in the signaling pathways that drive cancer progression. Dasatinib provides both first-line and later-line treatment options depending on the patient’s disease stage and previous therapies.

Dasatinib is available under the brand name Sprycel and various generics, manufactured in FDA-, EMA-, and MHRA-approved facilities for the USA, EU, and UK markets. Its use requires careful monitoring by healthcare professionals to manage potential side effects and ensure optimal outcomes.

By understanding the mechanism, indications, and administration of dasatinib, healthcare providers can deliver individualized treatment plans that improve patient outcomes and quality of life in leukemia management.